Study on pharmacokinetics of sustain-realease tablets of niacin and lovastatin in Beagle dogs

XU Wei-dong,ZHOU Wen,LI Bao-qiu,CUI Xiao-liang,ZHAO Yan-biao
DOI: https://doi.org/10.3969/j.issn.1672-7738.2006.11.027
2006-01-01
Abstract:OBJECTIVE To study the variation of pharmacokinetics parameters of sustain-realease tablets of niacin and lovastatin in Beagle dogs plasma.METHODS Single dose of sustained-release niacin and lovastatin formulation(500mg) and rapid-release niacin formulation(500mg) were given to dogs.To establish a RP-HPLC method for the detemination of niacin plasma concentration and its pharmacokinetics parameters.RESULTS The pharmacokinetics of sustained-release niacin and lovastatin formulation(500mg) and rapid-release niacin formulation in Beagle dogs was fitted to one-compartment model.The main pharmacokinetics parameters of the two pharmaceutical preparation were as follows: T_1/2(Ke) 64.99min vs.106.09min,T(peak)75.67min vs.112.20min,C(max)52.95μg·ml~(-1) vs.28.50μg·ml~(-1),AUC 10831.10 vs.9086.42μg·ml~(-1).CONCLUSION The T_1/2(Ke)、T(peak) of sustained-release niacin and lovastatin formulation is significantly longer than that of the conventional niacin tablet,the C_(max) was significantly lower than that of the conventional niacin tablet.The relative bioavailability is mainly coincident.The recovery of the method showed that the method had a good selectivity,sensitivity and reproducibility and can be used for pharmacokinetics studies of niacin.
What problem does this paper attempt to address?